Sort
172,184 grants matching “inflammation”
Program in Clinical Research, Clinical Support Services and Clinical Training
$5,483,797Janet Hall · National Institute Of Environmental Health Sciences · ZID · FY2024 · ES
Mapping the Human Connectome During Typical Aging
$5,482,616David C Van Essen · Washington University · U01 · FY2017 · AG
Investigating Correlates and Therapeutics of Fatigue in Cancer Patients
$5,482,508Leorey Saligan · National Institute Of Nursing Research · ZIA · FY2022 · NR
Southern Community Cohort Study
$5,481,150William J. Blot · Vanderbilt University · R01 · FY2007 · CA
Pathogenesis And Treatment Of Aplastic Anemia
$5,469,242Neal S Young · National Heart, Lung, And Blood Institute · ZIA · FY2009 · HL
Targeted Analysis Resource
$5,466,350John D. Meeker · University Of Michigan At Ann Arbor · U2C · FY2015 · ES
Southern Community Cohort Study
$5,456,051William J. Blot · Vanderbilt University · R01 · FY2008 · CA
Precision Monitoring and Assessment in the Framingham Study: Cognitive, MRI, Genetic and Biomarker Precursors of AD & Dementia
$5,451,688Lindsay A. Farrer · Boston University Medical Campus · U19 · FY2022 · AG
Systems Approach to Innate Immunity-Inflammation-Sepsis
$5,389,816Scripps Research Institute · U54 · FY2004 · AI
Southern Community Cohort Study
$5,377,011William J. Blot · Vanderbilt University · R01 · FY2010 · CA
Multi-Center Uveitis Steriod Treatment (MUST) Trial
$5,369,540Janet T. Holbrook · Johns Hopkins University · U10 · FY2008 · EY
MIND Diet Intervention to Prevent Alzheimer's Disease
$5,356,351Lisa L Barnes · Rush University Medical Center · R01 · FY2020 · AG
Program in Clinical Research, Clinical Support Services and Clinical Training
$5,332,395Janet Hall · National Institute Of Environmental Health Sciences · ZID · FY2023 · ES
Precision Monitoring and Assessment in the Framingham Study: Cognitive, MRI, Genetic and Biomarker Precursors of AD & Dementia
$5,319,931Lindsay A. Farrer · Boston University Medical Campus · U19 · FY2021 · AG
FDA approved IND 29644: Multicenter Phase 1 Trial to Evaluate Safety and Immunogenicity of Preventive Tau Vaccine, AV-1980R/A, in cognitively unimpaired preclinical AD participants.
$5,308,961Michael G Agadjanyan · Institute For Molecular Medicine · R01 · FY2025 · AG
Multimodal MRI in Multiple Sclerosis
$5,306,685Daniel Reich · National Institute Of Neurological Disorders And Stroke · ZIA · FY2025 · NS
Interdisciplinary Research to Understand the Interplay of Diabetes, Cerebrovascular disease and Alzheimers disease
$5,294,619Jose A Luchsinger · Columbia University Health Sciences · RF1 · FY2015 · AG
A Seamless Phase 2A-B Randomized Double Blind Placebo Controlled Trial to Evaluate the Efficacy and Safety of PQ 912 in Patients with Early Alzheimer's Disease
$5,279,327Howard Feldman · University Of California, San Diego · R01 · FY2019 · AG
Myocardial Ischemia and Transfusion (MINT) - CCC
$5,259,692Jeffrey Lee Carson · Rbhs-Robert Wood Johnson Medical School · U01 · FY2019 · HL
Genetic and epigenetic regulation of retinal development, aging and evolution
$5,254,111Anand Swaroop · National Eye Institute · ZIA · FY2023 · EY
Precision Monitoring and Assessment in the Framingham Study: Cognitive, MRI, Genetic and Biomarker Precursors of AD & Dementia
$5,244,895Lindsay A. Farrer · Boston University Medical Campus · U19 · FY2020 · AG
Mechanism Of Action And Functions Of The Gli-related Proteins Glis 1-3
$5,219,447Anton M Jetten · National Institute Of Environmental Health Sciences · ZIA · FY2025 · ES
The Dog Aging Project: Genetic and Environmental Determinants of Healthy Aging in Companion Dogs
$5,180,403Daniel Edward Lee Promislow · University Of Washington · U19 · FY2020 · AG
Skin microbes and development of allergic disease
$5,176,858Richard L Gallo · University Of California, San Diego · R01 · FY2025 · AI
Healthy Aging In Neighborhoods of Diversity Across the Life Span (HANDLS)
$5,173,553Michele K Evans · National Institute On Aging · ZIA · FY2022 · AG